Company: BNBX
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001410578-25-001320
Chunk: 2

Company: BNB PLUS CORP.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1F
Chunk 2
---
Item 1 - Financial Statements

APPLIED DNA SCIENCES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

​

​​​​​​​​    March 31,     September 30, ​​2025​2024ASSETS​(unaudited)​​​Current assets: ​   ​  Cash and cash equivalents​$ 6,823,260​$ 6,431,095Accounts receivable, net of allowance for credit losses of $82,723 and $75,000 at March 31, 2025 and September 30, 2024, respectively​  689,887​  362,013Inventories​  348,866​  438,592Prepaid expenses and other current assets​  568,398​  815,970Total current assets​  8,430,411​  8,047,670​​​​​​​Property and equipment, net​  683,887​  553,233Other assets:​  ​​  ​Restricted cash​​ 750,000​​ 750,000Intangible assets ​​ 2,698,975​​ 2,698,975Operating right of use asset​​ 472,390​​ 739,162Total assets​$ 13,035,663​$ 12,789,040​​​​​​​LIABILITIES AND EQUITY​   ​   ​​​​​​​Current liabilities:​ ​​   Accounts payable and accrued liabilities ​$ 1,409,628​$ 1,793,427Operating lease liability, current​​ 472,390​​ 545,912Deferred revenue​  12,285​  58,785Total current liabilities​  1,894,303​  2,398,124​​​ ​​​​Long term accrued liabilities​  31,467​  31,467Deferred revenue, long term​​ 194,000​​ 194,000Operating lease liability, long term​​ —​​ 193,249Deferred tax liability, net​​ 684,115​​ 684,115Warrants classified as a liability​​ 7,570​​ 320,000Total liabilities​  2,811,455​  3,820,955​​​​​​​Commitments and contingencies (Note G)​   ​   ​​​​​​​Applied